Cargando…
Polylysine-Containing Hydrogel Formulation of Fuzapladib, Inhibitor of Leukocyte-Function Associated Antigen-1 (LFA-1) Activation, for Sustained Release
The aim of the present study was to develop an injectable hydrogel (HG) formulation of fuzapladib sodium (FZP), an animal drug for acute pancreatitis (AP), with the use of polyethyleneoxide (PEO) and polylysine (pLys), a cationic polymer. A mixture of pLys and FZP was added to PEO to prepare an HG f...
Autores principales: | Higuchi, Koji, Yamada, Kohei, Kihara, Tsubasa, Makino, Keisuke, Sasaki, Kenta, Shindo, Takeshi, Shikama, Hiroshi, Sato, Hideyuki, Onoue, Satomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383447/ https://www.ncbi.nlm.nih.gov/pubmed/37513199 http://dx.doi.org/10.3390/molecules28145325 |
Ejemplares similares
-
Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis
por: Steiner, Joerg M., et al.
Publicado: (2023) -
Fuzapladib reduces postsurgical inflammation in the intestinal muscularis externa
por: KAJI, Noriyuki, et al.
Publicado: (2023) -
Divalent cation regulation of the function of the leukocyte integrin LFA-1
Publicado: (1992) -
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes
por: Manikwar, Prakash, et al.
Publicado: (2011) -
Coordinated Redistribution of Leukocyte LFA-1 and Endothelial Cell ICAM-1 Accompany Neutrophil Transmigration
por: Shaw, Sunil K., et al.
Publicado: (2004)